Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complex Regional Pain Syndromes | 5 | 2022 | 14 | 2.080 |
Why?
|
| Cytokines | 3 | 2022 | 2809 | 0.980 |
Why?
|
| Fibromyalgia | 3 | 2017 | 12 | 0.790 |
Why?
|
| Low Back Pain | 3 | 2013 | 83 | 0.580 |
Why?
|
| Facial Pain | 1 | 2015 | 20 | 0.550 |
Why?
|
| Persian Gulf Syndrome | 1 | 2015 | 14 | 0.540 |
Why?
|
| Stress, Psychological | 3 | 2015 | 1000 | 0.540 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 47 | 0.540 |
Why?
|
| Anxiety | 3 | 2015 | 1179 | 0.540 |
Why?
|
| Statistics as Topic | 2 | 2015 | 445 | 0.510 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 75 | 0.480 |
Why?
|
| Immunoassay | 1 | 2013 | 216 | 0.440 |
Why?
|
| Pain Management | 2 | 2015 | 668 | 0.420 |
Why?
|
| Specimen Handling | 1 | 2013 | 299 | 0.400 |
Why?
|
| Depression | 3 | 2015 | 1715 | 0.390 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 423 | 0.370 |
Why?
|
| Whiplash Injuries | 1 | 2010 | 3 | 0.370 |
Why?
|
| Patient Care Team | 1 | 2015 | 795 | 0.370 |
Why?
|
| Hypesthesia | 1 | 2010 | 22 | 0.360 |
Why?
|
| Neck Pain | 1 | 2010 | 39 | 0.360 |
Why?
|
| Affect | 1 | 2011 | 288 | 0.360 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 181 | 0.350 |
Why?
|
| Chronic Pain | 3 | 2018 | 238 | 0.310 |
Why?
|
| Wrist Injuries | 2 | 2018 | 12 | 0.300 |
Why?
|
| Brain | 2 | 2021 | 4113 | 0.270 |
Why?
|
| Depressive Disorder | 1 | 2010 | 557 | 0.270 |
Why?
|
| Pain | 4 | 2022 | 1658 | 0.270 |
Why?
|
| Pain Measurement | 4 | 2015 | 953 | 0.230 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2023 | 17 | 0.230 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 15 | 0.220 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 4320 | 0.210 |
Why?
|
| Neurogenesis | 2 | 2021 | 238 | 0.210 |
Why?
|
| Radiation Exposure | 1 | 2022 | 73 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 205 | 0.190 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 86 | 0.190 |
Why?
|
| Quality of Life | 1 | 2014 | 4532 | 0.190 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 94 | 0.190 |
Why?
|
| Space Flight | 1 | 2022 | 158 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 238 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2022 | 6100 | 0.180 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2019 | 24 | 0.180 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 34 | 0.170 |
Why?
|
| Hand Bones | 1 | 2018 | 8 | 0.170 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 96 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 492 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 1073 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2011 | 1819 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2018 | 291 | 0.130 |
Why?
|
| Hand Injuries | 1 | 2015 | 18 | 0.130 |
Why?
|
| Cerebellum | 1 | 2019 | 449 | 0.130 |
Why?
|
| Progesterone | 1 | 2017 | 513 | 0.130 |
Why?
|
| Hippocampus | 1 | 2021 | 915 | 0.130 |
Why?
|
| Neutrophils | 1 | 2019 | 835 | 0.120 |
Why?
|
| Demography | 1 | 2015 | 435 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 987 | 0.120 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.120 |
Why?
|
| Physical Therapy Specialty | 1 | 2013 | 6 | 0.120 |
Why?
|
| Freezing | 1 | 2013 | 59 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2015 | 121 | 0.120 |
Why?
|
| Chemokine CCL4 | 1 | 2013 | 63 | 0.120 |
Why?
|
| Naltrexone | 1 | 2014 | 87 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1491 | 0.110 |
Why?
|
| Blister | 1 | 2013 | 31 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 68 | 0.110 |
Why?
|
| Testosterone | 1 | 2017 | 619 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 390 | 0.110 |
Why?
|
| Acute Pain | 1 | 2013 | 42 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2013 | 117 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2013 | 5687 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2013 | 298 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2022 | 12873 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2022 | 9244 | 0.100 |
Why?
|
| Logistic Models | 1 | 2018 | 3441 | 0.100 |
Why?
|
| Pain Clinics | 1 | 2010 | 17 | 0.100 |
Why?
|
| Young Adult | 5 | 2017 | 21445 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2011 | 170 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 461 | 0.090 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 98 | 0.090 |
Why?
|
| Male | 9 | 2018 | 123000 | 0.080 |
Why?
|
| Middle Aged | 8 | 2018 | 86204 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 304 | 0.080 |
Why?
|
| Female | 9 | 2018 | 141928 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 6009 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 621 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1987 | 203 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 748 | 0.070 |
Why?
|
| Australia | 2 | 2018 | 225 | 0.060 |
Why?
|
| Adult | 6 | 2018 | 77950 | 0.060 |
Why?
|
| Veterans | 1 | 2015 | 1641 | 0.060 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2023 | 14 | 0.060 |
Why?
|
| Disability Evaluation | 2 | 2015 | 249 | 0.060 |
Why?
|
| Moon | 1 | 2022 | 14 | 0.060 |
Why?
|
| Hydrolases | 1 | 2023 | 123 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 264 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 347 | 0.050 |
Why?
|
| Biology | 1 | 2021 | 75 | 0.050 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 73 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 31252 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 482 | 0.040 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 38 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 664 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 233 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 927 | 0.040 |
Why?
|
| Aged | 4 | 2017 | 70117 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 1380 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 749 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 59536 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 333 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 1217 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 34495 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 38 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 3033 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1945 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 1121 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 223 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 1582 | 0.030 |
Why?
|
| Proprioception | 1 | 2010 | 21 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2010 | 76 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2010 | 130 | 0.020 |
Why?
|
| Neurons | 1 | 2021 | 2287 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2015 | 1171 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 1987 | 11 | 0.020 |
Why?
|
| New Zealand | 1 | 1987 | 60 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 462 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 590 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 1248 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1987 | 94 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 667 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7222 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4314 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 915 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2010 | 899 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 860 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 11965 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 7702 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 14889 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 37905 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 32848 | 0.010 |
Why?
|